Gynuity Health Projects

Resources

Resources by Author

Abalos, E.

Advance misoprostol distribution for preventing and treating postpartum haemorrhage

Byrne, M.E.

A crossover pharmacokinetic study of misoprostol by the oral, sublingual and buccal routes

Abbas, Dina

Misoprostol for prevention and treatment of postpartum hemorrhage: What do we know? What is next?

Outpatient medical abortion is safe and effective through 70 days gestation

Simultaneous Administration Compared With a 24-Hour Mifepristone-Misoprostol Interval

O'Brien, P.A.

Progestin-only pills for contraception

International Women's Health Coalition

Abortion With Self-Administered Misoprostol: A Guide For Women

Abdel-Aleem, H.

Misoprostol: adjunct treatment to standard uterotonics for treatment of PPH

Abrahamyan, R.

Second trimester MA with mifepristone followed by unlimited dosing of buccal misoprostol in Armenia

Abou El Senoun, G.

Treatment for primary postpartum haemorrhage

Abiola, Okunlola Michael

Incomplete abortion in five sub-Saharan African countries

Abdel-Aleem, Mahmoud

Misoprostol: adjunct treatment to standard uterotonics for treatment of PPH

Adeyanju, Alaruru O.

Misoprostol as first-line treatment for incomplete abortion in Nigeria

Abuabara, Katrina

Medical Abortion Guidebook

Aga Khan University Karachi

Misoprostol for the Prevention of Postpartum Hemorrhage: Findings from Research in Pakistan

Ahmed, S.

Community-based kangaroo mother care to prevent neonatal and infant mortality

Akin, Ayse

Increasing women's choices in medical abortion in Turkey

Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone

Albutt, K.

Sexual violence-related pregnancies in eastern Democratic Republic of Congo

Aksan, Guldeniz

Increasing women's choices in medical abortion in Turkey

Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone

Alam, A.

Acceptability and Feasibility of Mifepristone-Misoprostol For Menstrual Regulation in Bangladesh

Mifepristone–misoprostol for menstrual regulation in public sector facilities in Bangladesh

Aktun, Hale

Increasing women's choices in medical abortion in Turkey

Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone

Alfirevic, Zarko

Prevention of postpartum hemorrhage with misoprostol

Treatment of postpartum hemorrhage with misoprostol

Treatment for primary postpartum haemorrhage

Preventing postpartum hemorrhage at the community level

Misoprostol-induced fever and genetic polymorphisms in drug transporters

Foley catheterisation versus oral misoprostol for induction of labour in hypertensive women in India

Aldrich, Tess

Methotrexate compared to misoprostol alone for early medical abortion

Improving Current Therapies and Exploring New Options in Abortifacient Technology

What measured blood loss tells us about postpartum bleeding

Aliyeva, F.

Acceptability and feasibility of mifepristone medical abortion in the early first trimester in Azerb

Ali, R.

Prophylactic compared with therapeutic Ibuprofen analgesia in first-trimester medical abortion

Ambardekar, S.

Calibrated delivery drape versus indirect gravimetric technique for the measurement of blood loss

Alpert, Lindsay

Alternatives to routine ultrasound for eligibility assessment prior to medical abortion

Ardeshana, A.

Misoprostol-induced fever and genetic polymorphisms in drug transporters

Aranguré Peraza, A. G.

Safety, efficacy and acceptability of outpatient mifepristone-misoprostol MA through 70 days

Effects of Depot Medroxyprogesterone Acetate Injection Timing on MA Efficacy and Repeat Pregnancy

Anger, Holly

Misoprostol for the management of postpartum bleeding: A new approach

Arellano, Monica

Oral Misoprostol for the Management of Incomplete Abortion in Ecuador

Aronoff, D. M.

800μg misoprostol and mucosal and systemic immune activation or the cervicovaginal microbiome

Aryal, K.

Aryal, S.

Aremu, Oyewole T.

Misoprostol as first-line treatment for incomplete abortion in Nigeria

Assoumou, Pamphile

First experience of the use of misoprostol as post-abortion care in Libreville, Gabon.

Arnesen, Michelle

At-home semi-quantitative pregnancy tests as replacement for clinical follow-up of medical abortion

Prophylactic compared with therapeutic Ibuprofen analgesia in first-trimester medical abortion

Ambardekar, Shubha

Are two doses of misoprostol after mifepristone for early abortion better than one?

Mifepristone for late first trimester abortion

Avagyan, Gayane

Knowledge, attitudes, and practice of abortion among women and doctors in Armenia

The introduction of first trimester medical abortion in Armenia

Second trimester MA with mifepristone followed by unlimited dosing of buccal misoprostol in Armenia

Bahamondes, L.

Evaluation of efficacy, safety & acceptability of pericoital oral contraception with levonorgestrel

A single-arm study to evaluate the efficacy, safety and acceptability of pericoital oral contracept

Ban, B.

Bal Sall, Aissata

Incomplete abortion in five sub-Saharan African countries

Banks, E.

Buccal misoprostol for IUFD Research Group

Ball, Carol

Outpatient medical abortion through 70 days

Barnett, L.

800μg misoprostol and mucosal and systemic immune activation or the cervicovaginal microbiome

Bannikov, V.

Efficacy and acceptability of early mifepristone-misoprostol medical abortion in Ukraine

Barajas, Adriana

Alternatives to routine ultrasound for eligibility assessment prior to medical abortion

Barnhart, Kurt T.

Exploration of a new procedure for sterilization

Bartels, S.

Sexual violence-related pregnancies in eastern Democratic Republic of Congo

Baber, Neelofur

Misoprostol in addition to routine treatment of postpartum hemorrhage in Pakistan

Bernardin, J.

Medical abortion

Bednarek, P. H.

Cervical Preparation Before Dilation and Evacuation Using Adjunctive Misoprostol or Mifepristone

Barua, Alka

Facility and personnel factors influencing magnesium sulfate use for eclampsia and preeclampsia

Black, A.

Medical abortion

Barrera, Gustavo

Sublingual misoprostol vs oxytocin in women not exposed to oxytocin during labor

High fever following postpartum administration of sublingual misoprostol

Dose and side effects of sublingual misoprostol for treatment of postpartum hemorrhage

Biswas, Bivas

Treatment approaches for preeclampsia in low-resource settings

Bique, Cassimo

Misoprostol for incomplete abortion in Mozambique

Blandine, Thieba

Oral misoprostol as first-line care for incomplete abortion in Burkina Faso

Incomplete abortion in five sub-Saharan African countries

Blignaut, Quentin

Misoprostol to augment routine active management of the third stage of labor

Bokhua, Z.

Acceptability & feasibility of 400μg buccal misoprostol after 200 mg mife for early MA in Georgia

Blanchard, Kelly

Assessment of pregnancy duration among termination of pregnancy clients in South Africa

Integrating medical abortion into safe abortion services in South Africa

Self-induction of abortion among women in the United States

Sixteen Years of Overregulation: Time to Unburden Mifeprex

Blum, Jennifer

Misoprostol for incomplete abortion in Burkina Faso

Treatment of incomplete abortion and miscarriage with misoprostol

Prevention of postpartum hemorrhage with misoprostol

Treatment of postpartum hemorrhage with misoprostol

Misoprostol: A New Addition to Post Abortion Care

Medical Abortion Guidebook

Misoprostol in addition to routine treatment of postpartum hemorrhage in Pakistan

Sublingual misoprostol vs oxytocin in women not exposed to oxytocin during labor

Sublingual misoprostol vs oxytocin in women receiving prophylactic oxytocin

What measured blood loss tells us about postpartum bleeding

Misoprostol: adjunct treatment to standard uterotonics for treatment of PPH

Sublingual misoprostol vs. MVA for the treatment of incomplete abortion in Egypt

Oral misoprostol as an alternative to surgical management for incomplete abortion in Ghana

Administration of misoprostol by trained TBAs to prevent PPH in homebirths in Pakistan

Misoprostol to augment routine active management of the third stage of labor

Comparing two early medical abortion regimens: Mifepristone+misoprostol vs. misoprostol alone

Mifepristone and Misoprostol Compared With Misoprostol Alone for Second-trimester Abortion

Misoprostol for the prevention and treatment of postpartum hemorrhage

Comparison of regimens for home-based early medical abortion in Tunisia and Vietnam

At-home semi-quantitative pregnancy tests as replacement for clinical follow-up of medical abortion

Oral misoprostol as first-line care for incomplete abortion in Burkina Faso

Misoprostol for the management of postpartum bleeding: A new approach

Simplified medical abortion using a semi-quantitative pregnancy test for home-based follow-up

Results from a study using misoprostol for management of incomplete abortion in Vietnamese hospitals

Acceptability and feasibility of phone follow-up after early medical abortion in Vietnam

WHO Multicountry Survey on Maternal and Newborn Health Research Network

Treatment for primary postpartum haemorrhage

How effective are the components of active management of the third stage of labor?

Determining early medical abortion outcomes at 3, 7 and 14 days after mifepristone

Oxytocin via Uniject versus oral misoprostol for prevention of postpartum haemorrhage

Simultaneous Administration Compared With a 24-Hour Mifepristone-Misoprostol Interval

Serial Multilevel Urine Pregnancy Testing to Assess Medical Abortion Outcome

Dissemination and implementing a core outcome set for medical and surgical abortion

Results of a pilot study in the U.S. and Vietnam to assess the utility and acceptability of a MLPT

Advance misoprostol distribution for preventing and treating postpartum haemorrhage

Misoprostol in the management of the third stage of labour in the home delivery in Gambia

Box, H.

Misoprostol-induced fever and genetic polymorphisms in drug transporters

Bousiéguez, Manuel

Efficacy and acceptability of a mifepristone-misoprostol combined regimen for early induced abortion

Safety, efficacy and acceptability of outpatient mifepristone-misoprostol MA through 70 days

Effects of Depot Medroxyprogesterone Acetate Injection Timing on MA Efficacy and Repeat Pregnancy

Blumenthal, Paul

The supreme court and the partial-birth abortion ban act of 2003

Sublingual misoprostol for incomplete abortion

At-home semi-quantitative pregnancy tests as replacement for clinical follow-up of medical abortion

Simplified medical abortion using a semi-quantitative pregnancy test for home-based follow-up

Acceptability and feasibility of phone follow-up after early medical abortion in Vietnam

Buccal misoprostol for IUFD Research Group

Determining early medical abortion outcomes at 3, 7 and 14 days after mifepristone

Innovative research at the 2016 National Abortion Federation Annual Meeting

Serial Multilevel Urine Pregnancy Testing to Assess Medical Abortion Outcome

Sixteen Years of Overregulation: Time to Unburden Mifeprex

Results of a pilot study in the U.S. and Vietnam to assess the utility and acceptability of a MLPT

Brahmi, D.

Dissemination and implementing a core outcome set for medical and surgical abortion

Borgatta, Lynn

Alternatives to mifepristone for early medical abortion

Brady, Leanne

Misoprostol to augment routine active management of the third stage of labor

Burkhardt, G.

Sexual violence-related pregnancies in eastern Democratic Republic of Congo

Bracken, Hillary

Are two doses of misoprostol after mifepristone for early abortion better than one?

Mifepristone for late first trimester abortion

Perspectives on reproductive decision-making amongst HIV-infected individuals

Reproductive intentions among HIV-positive women and men

Route of Misoprostol Administration

Abortion and sex determination

Mifepristone medical abortion in Albania

Medical Abortion Guidebook

Sublingual misoprostol after mifepristone

Acceptability and feasibility of medical abortion in Nepal

Home administration of misoprostol for early medical abortion in India

Alternatives to Routine Follow-Up for Early Medical Abortion

Introduction and provision of medical abortion: A tale of two countries

Review of the Literature on Patient Satisfaction with Early Medical Abortion

Treatment approaches for preeclampsia in low-resource settings

Facility and personnel factors influencing magnesium sulfate use for eclampsia and preeclampsia

Acceptability and Feasibility of Mifepristone-Misoprostol For Menstrual Regulation in Bangladesh

A two-pill sublingual misoprostol outpatient regimen following mife for MA through 70 days' LMP

Acceptability and feasibility of phone follow-up after early medical abortion in Vietnam

Buccal misoprostol for IUFD Research Group

Calibrated delivery drape versus indirect gravimetric technique for the measurement of blood loss

A prospective open-label study of home use of mifepristone for medical abortion in Nepal

Early Medical Abortion without Prior Ultrasound

Alternatives to routine ultrasound for eligibility assessment prior to medical abortion

Serial Multilevel Urine Pregnancy Testing to Assess Medical Abortion Outcome

Foley catheterisation versus oral misoprostol for induction of labour in hypertensive women in India

What Is the Most Effective, Low-Cost Method for Inducing Labor in Women With Pre-Eclampsia?

Mifepristone–misoprostol for menstrual regulation in public sector facilities in Bangladesh

Byamugisha, Josaphat

Preventing postpartum hemorrhage at the community level

The MamaMiso study of self-administered misoprostol to prevent bleeding after childbirth in Uganda

Burke, Anne E.

Combined hormonal contraceptives and venous thromboembolism

Achieving community-based postpartum follow up in eastern Uganda

Bynum, Jillian

Guidebook on Misoprostol for Treatment of Incomplete Abortion

High fever following postpartum administration of sublingual misoprostol

Córdova, Denisse

Self-induction of abortion among women in the United States

Cates, W.

Progestin-only Pills

Contraceptive Implants

Chelli, Héla

Comparison of regimens for home-based early medical abortion in Tunisia and Vietnam

A double-blind randomized controlled trial of mifepristone or placebo before buccal misoprostol

A two-pill sublingual misoprostol outpatient regimen following mife for MA through 70 days' LMP

Self-administered multi-level pregnancy tests in simplified follow-up of medical abortion in Tunisia

Chen, B. A.

Cervical Preparation Before Dilation and Evacuation Using Adjunctive Misoprostol or Mifepristone

Carroli, Guillermo

Misoprostol: adjunct treatment to standard uterotonics for treatment of PPH

Cheng, L.

Letter to the editor on Emergency Contraception

Cherine Ramadan, Mohamed

Sublingual misoprostol vs oxytocin in women receiving prophylactic oxytocin

Sublingual misoprostol vs. MVA for the treatment of incomplete abortion in Egypt

Chi, Huynh Thi Kim

Sublingual misoprostol vs oxytocin in women not exposed to oxytocin during labor

Simultaneous Administration Compared With a 24-Hour Mifepristone-Misoprostol Interval

Chong, Erica

Misoprostol for incomplete abortion in Mozambique

Knowledge, attitudes, and practice of abortion among women and doctors in Armenia

Two doses of buccal misoprostol following mifepristone

Acceptability of home use of mifepristone for medical abortion

Outpatient medical abortion through 70 days

Acceptability and feasibility of mifepristone medical abortion in the early first trimester in Azerb

The introduction of first trimester medical abortion in Armenia

What happens when we routinely give doxycycline to medical abortion patients?

Outpatient medical abortion is safe and effective through 70 days gestation

Increasing Access to Abortion With Telemedicine

Second trimester MA with mifepristone followed by unlimited dosing of buccal misoprostol in Armenia

800μg misoprostol and mucosal and systemic immune activation or the cervicovaginal microbiome

Acceptability & feasibility of 400μg buccal misoprostol after 200 mg mife for early MA in Georgia

Chowdhury, M.

Community-based kangaroo mother care to prevent neonatal and infant mortality

Clotaire, Hien

Oral misoprostol as first-line care for incomplete abortion in Burkina Faso

Cleland, K.

Emergency Contraception: A Last Chance to Prevent Unintended Pregnancy

Letter to the editor on Emergency Contraception

Sixteen Years of Overregulation: Time to Unburden Mifeprex

Clark, Wesley

Use of sequential serum hCG and sonography for medical abortion only when indicated

Can mifepristone medical abortion be simplified?

Misoprostol for incomplete abortion in Tanzania

Misoprostol for uterine evacuation in induced abortion and pregnancy failure

Alternatives to Routine Follow-Up for Early Medical Abortion

Alternatives to routine ultrasound for eligibility assessment prior to medical abortion

Coeytaux, F.

Embracing post-fertilisation methods of family planning: a call to action

Study finds that obtaining abortion pills from the internet is feasible in the US

Comstock, Ioanna A.

Results of a pilot study in the U.S. and Vietnam to assess the utility and acceptability of a MLPT

Conkling, Kathryn

Comparison of regimens for home-based early medical abortion in Tunisia and Vietnam

A prospective open-label study of home use of mifepristone for medical abortion in Nepal

Comendant, Rodica

Sublingual misoprostol after mifepristone

Sublingual misoprostol for incomplete abortion

Buccal vs. sublingual misoprostol after mifepristone for medical abortion

Phone follow-up with SQPT after medical abortion in Moldova and Uzbekistan

Coral, Angela

Oral misoprostol as first-line care for incomplete abortion in Burkina Faso

Costescu, D.

Medical abortion

Cooper, Diane

Assessment of pregnancy duration among termination of pregnancy clients in South Africa

Perspectives on reproductive decision-making amongst HIV-infected individuals

Reproductive intentions among HIV-positive women and men

Integrating medical abortion into safe abortion services in South Africa

Coyaji, Kurus

Are two doses of misoprostol after mifepristone for early abortion better than one?

Mifepristone for late first trimester abortion

Calibrated delivery drape versus indirect gravimetric technique for the measurement of blood loss

Creinin, Mitchell

Two distinct oral routes of misoprostol in mifepristone medical abortion

Dissemination and implementing a core outcome set for medical and surgical abortion

Crumbo, K.

800μg misoprostol and mucosal and systemic immune activation or the cervicovaginal microbiome

Crowden, William

Two distinct oral routes of misoprostol in mifepristone medical abortion

Medical abortion: Outcomes in a family medicine setting

Outpatient medical abortion through 70 days

Culwell, K. R.

Effects of Depot Medroxyprogesterone Acetate Injection Timing on MA Efficacy and Repeat Pregnancy

Curley, P.

Misoprostol-induced fever and genetic polymorphisms in drug transporters

Curtis, K. M.

Hormonal contraceptive methods and risk of HIV acquisition in women

Cullingworth, Lee

Assessment of pregnancy duration among termination of pregnancy clients in South Africa

Integrating medical abortion into safe abortion services in South Africa

Dampha, M.

Misoprostol in the management of the third stage of labour in the home delivery in Gambia

Daff, B.

Oxytocin via Uniject versus oral misoprostol for prevention of postpartum haemorrhage

Dabash, Rasha

Comparison of regimens for home-based early medical abortion in Tunisia and Vietnam

Abortion in the Middle East and North Africa

Increasing women's choices in medical abortion in Turkey

Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone

Sublingual misoprostol vs oxytocin in women not exposed to oxytocin during labor

Sublingual misoprostol vs oxytocin in women receiving prophylactic oxytocin

A double-blind randomized controlled trial of mifepristone or placebo before buccal misoprostol

Sublingual misoprostol vs. MVA for the treatment of incomplete abortion in Egypt

Comparing two early medical abortion regimens: Mifepristone+misoprostol vs. misoprostol alone

Review of the Literature on Patient Satisfaction with Early Medical Abortion

Misoprostol for the management of postpartum bleeding: A new approach

Sublingual Misoprostol for the Treatment of Postpartum Hemorrhage

A two-pill sublingual misoprostol outpatient regimen following mife for MA through 70 days' LMP

Serial Multilevel Urine Pregnancy Testing to Assess Medical Abortion Outcome

Self-administered multi-level pregnancy tests in simplified follow-up of medical abortion in Tunisia

Das, T.R.

Mifepristone–misoprostol for menstrual regulation in public sector facilities in Bangladesh

Dao, Blami

Misoprostol for incomplete abortion in Burkina Faso

Sublingual misoprostol vs oxytocin in women receiving prophylactic oxytocin

Oral misoprostol as first-line care for incomplete abortion in Burkina Faso

Incomplete abortion in five sub-Saharan African countries

Darwish, Emad

Sublingual misoprostol vs oxytocin in women not exposed to oxytocin during labor

Sublingual misoprostol vs. MVA for the treatment of incomplete abortion in Egypt

Davis, Anne Rachel

Abortion is for women

Dean, Gillian

Outpatient medical abortion through 70 days

Prophylactic compared with therapeutic Ibuprofen analgesia in first-trimester medical abortion

DePiñeres, T.

Dissemination and implementing a core outcome set for medical and surgical abortion

Derman, R. J.

Buccal misoprostol for IUFD Research Group

Diagne, M.

Oxytocin via Uniject versus oral misoprostol for prevention of postpartum haemorrhage

Dickens, D.

Misoprostol-induced fever and genetic polymorphisms in drug transporters

Debora, B.

Misoprostol for incomplete abortion in Mozambique

Dickson, Kim

Assessment of pregnancy duration among termination of pregnancy clients in South Africa

Integrating medical abortion into safe abortion services in South Africa

Digol, Irena

Sublingual misoprostol after mifepristone

Buccal vs. sublingual misoprostol after mifepristone for medical abortion

Dilbaz, Berna

Increasing women's choices in medical abortion in Turkey

Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone

Sublingual misoprostol vs oxytocin in women receiving prophylactic oxytocin

Ditai, James

Preventing postpartum hemorrhage at the community level

The MamaMiso study of self-administered misoprostol to prevent bleeding after childbirth in Uganda

Achieving community-based postpartum follow up in eastern Uganda

Diop, Ayisha

Sublingual misoprostol for incomplete abortion

Sublingual misoprostol vs oxytocin in women receiving prophylactic oxytocin

Oral misoprostol as an alternative to surgical management for incomplete abortion in Ghana

Comparing two early medical abortion regimens: Mifepristone+misoprostol vs. misoprostol alone

Oral misoprostol as first-line care for incomplete abortion in Burkina Faso

Misoprostol as first-line treatment for incomplete abortion in Nigeria

Incomplete abortion in five sub-Saharan African countries

Acceptability and feasibility of medical abortion with mifepristone and misoprostol in Nigeria

Decentralizing postabortion care in Senegal with misoprostol for incomplete abortion

First experience of the use of misoprostol as post-abortion care in Libreville, Gabon.

Oxytocin via Uniject versus oral misoprostol for prevention of postpartum haemorrhage

Dolo, Obed

Oral misoprostol as an alternative to surgical management for incomplete abortion in Ghana

Dondiuc, Lurie

Buccal vs. sublingual misoprostol after mifepristone for medical abortion

Dowd, S. E.

800μg misoprostol and mucosal and systemic immune activation or the cervicovaginal microbiome

Drake, J.K.

What some women want? On-demand oral contraception

Dragoman, M. V.

Two prophylactic medication approaches in addition to a pain control regimen for early MA

Drey, E. A.

Cervical Preparation Before Dilation and Evacuation Using Adjunctive Misoprostol or Mifepristone

Duffy, J.M.

Dissemination and implementing a core outcome set for medical and surgical abortion

Dung, D. L.

Two prophylactic medication approaches in addition to a pain control regimen for early MA

Dogan, Bahar

Increasing women's choices in medical abortion in Turkey

Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone

Dunn, S.

Regimens of misoprostol with mifepristone for early medical abortion

Medical abortion

Durocher, Jill

Misoprostol in addition to routine treatment of postpartum hemorrhage in Pakistan

Sublingual misoprostol vs oxytocin in women not exposed to oxytocin during labor

Sublingual misoprostol vs oxytocin in women receiving prophylactic oxytocin

High fever following postpartum administration of sublingual misoprostol

What measured blood loss tells us about postpartum bleeding

Administration of misoprostol by trained TBAs to prevent PPH in homebirths in Pakistan

Oral Misoprostol for the Management of Incomplete Abortion in Ecuador

Misoprostol for the prevention and treatment of postpartum hemorrhage

Treatment approaches for preeclampsia in low-resource settings

Dose and side effects of sublingual misoprostol for treatment of postpartum hemorrhage

A new formulation of misoprostol is unlikely to revolutionise postpartum haemorrhage care

How effective are the components of active management of the third stage of labor?

Preventing postpartum hemorrhage at the community level

The MamaMiso study of self-administered misoprostol to prevent bleeding after childbirth in Uganda

Misoprostol-induced fever and genetic polymorphisms in drug transporters

Profound Hyperthermia After Postpartum Rectal Misoprostol Administration

Achieving community-based postpartum follow up in eastern Uganda

Dutton, C.

Cervical Preparation Before Dilation and Evacuation Using Adjunctive Misoprostol or Mifepristone

Dursun, Polat

Increasing women's choices in medical abortion in Turkey

Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone

Easterling, Thomas

Treatment approaches for preeclampsia in low-resource settings

Facility and personnel factors influencing magnesium sulfate use for eclampsia and preeclampsia

Foley catheterisation versus oral misoprostol for induction of labour in hypertensive women in India

Elati, A.

Misoprostol-induced fever and genetic polymorphisms in drug transporters

Dzuba, Ilana

Two distinct oral routes of misoprostol in mifepristone medical abortion

Sublingual misoprostol vs oxytocin in women receiving prophylactic oxytocin

Medical abortion: Outcomes in a family medicine setting

Outpatient medical abortion through 70 days

Sublingual Misoprostol for the Treatment of Postpartum Hemorrhage

Medical abortion: A path to safe, high-quality abortion care in Latin America and the Caribbean

Efficacy and acceptability of a mifepristone-misoprostol combined regimen for early induced abortion

Safety, efficacy and acceptability of outpatient mifepristone-misoprostol MA through 70 days

Off-label indications for mifepristone in gynecology and obstetrics

Elul, Batya

Early pregnancy termination

Espey, Eve

Combined hormonal contraceptives and venous thromboembolism

Family Care International

Postpartum hemorrhage: Moving from Research to Reality

Postpartum Hemorrhage: A Challenge for Safe Motherhood

Blood Loss After Vaginal Delivery

Fever after treatment of postpartum hemorrhage

Misoprostol for the Prevention of Postpartum Hemorrhage: Findings from Research in Pakistan

Misoprostol for the Treatment of Postpartum Hemorrhage: Findings from Clinical Research Trials

Faragher, Brian

Preventing postpartum hemorrhage at the community level

The MamaMiso study of self-administered misoprostol to prevent bleeding after childbirth in Uganda

Foley catheterisation versus oral misoprostol for induction of labour in hypertensive women in India

Fawole, Adeniran O.

Misoprostol as first-line treatment for incomplete abortion in Nigeria

Fawole, Bukola

Misoprostol to augment routine active management of the third stage of labor

Incomplete abortion in five sub-Saharan African countries

Advance misoprostol distribution for preventing and treating postpartum haemorrhage

Fine, P. M.

Evaluation of efficacy, safety & acceptability of pericoital oral contraception with levonorgestrel

A single-arm study to evaluate the efficacy, safety and acceptability of pericoital oral contracept

Fitzmaurice, G. M.

Cervical Preparation Before Dilation and Evacuation Using Adjunctive Misoprostol or Mifepristone

Fitzsimmons, B.

Medical abortion

Fischer, Dick

At-home semi-quantitative pregnancy tests as replacement for clinical follow-up of medical abortion

Fjerstad, Mary

Foster, A. M.

Sixteen Years of Overregulation: Time to Unburden Mifeprex

Fortin, Jennifer

Medical abortion: Outcomes in a family medicine setting

Cervical Preparation Before Dilation and Evacuation Using Adjunctive Misoprostol or Mifepristone

Family Planning Association of India (FPAI)

Home administration of misoprostol for early medical abortion in India

Ganatra, B.

Dissemination and implementing a core outcome set for medical and surgical abortion

García Martinez, L. G.

Safety, efficacy and acceptability of outpatient mifepristone-misoprostol MA through 70 days

Friptu, Valentin

Sublingual misoprostol after mifepristone

Frye, Laura

Claims of misoprostol use based on blood sampling should be viewed with skepticism

What happens when we routinely give doxycycline to medical abortion patients?

Preventing postpartum hemorrhage at the community level

The MamaMiso study of self-administered misoprostol to prevent bleeding after childbirth in Uganda

Is It Safe to Provide Abortion Pills Over The Counter?

A crossover pharmacokinetic study of misoprostol by the oral, sublingual and buccal routes

Profound Hyperthermia After Postpartum Rectal Misoprostol Administration

Achieving community-based postpartum follow up in eastern Uganda

Gülmezoglu, A.

WHO Multicountry Survey on Maternal and Newborn Health Research Network

Dissemination and implementing a core outcome set for medical and surgical abortion

Gaye, Alioune

Incomplete abortion in five sub-Saharan African countries

Decentralizing postabortion care in Senegal with misoprostol for incomplete abortion

Gómez Ponce de León, Rodolfo

Misoprostol to treat missed abortion in the first trimester

Gillespie, Ginger

Medical abortion: Outcomes in a family medicine setting

Ginde, S. Y.

Evaluation of efficacy, safety & acceptability of pericoital oral contraception with levonorgestrel

A single-arm study to evaluate the efficacy, safety and acceptability of pericoital oral contracept

Gemzell Danielsson, Kristina

Misoprostol to treat missed abortion in the first trimester

Treatment of incomplete abortion and miscarriage with misoprostol

Embracing post-fertilisation methods of family planning: a call to action

Dissemination and implementing a core outcome set for medical and surgical abortion

Gold, K.

Medical abortion

Godi, N. Patrick

Misoprostol to augment routine active management of the third stage of labor

Gliozheni, Orion

Mifepristone medical abortion in Albania

Gold, Marji

Use of sequential serum hCG and sonography for medical abortion only when indicated

Can mifepristone medical abortion be simplified?

Self-induction of abortion among women in the United States

Acceptability of home use of mifepristone for medical abortion

Buccal misoprostol for IUFD Research Group

Sixteen Years of Overregulation: Time to Unburden Mifeprex

Granby, Paul

Foley catheterisation versus oral misoprostol for induction of labour in hypertensive women in India

Grebennikova, G.

Prospective study of home use of mifepristone and misoprostol for medical abortion up to 10weeks

Home use of mifepristone and misoprostol for MA up to 10weeks of pregnancy in Kazakhstan

Greiner, A.

Sexual violence-related pregnancies in eastern Democratic Republic of Congo

Goldberg, Alisa

Two distinct oral routes of misoprostol in mifepristone medical abortion

Outpatient medical abortion through 70 days

Cervical Preparation Before Dilation and Evacuation Using Adjunctive Misoprostol or Mifepristone

Effects of Depot Medroxyprogesterone Acetate Injection Timing on MA Efficacy and Repeat Pregnancy

Grimes, David A.

Medical abortion for adolescents

Feticidal digoxin before D&E

The comparative safety of legal induced abortion and childbirth in the United States

Progestin-only pills for contraception

Spermicide used alone for contraception

Gonzales, Juliana

Two distinct oral routes of misoprostol in mifepristone medical abortion

Grossman, Daniel

Can mifepristone medical abortion be simplified?

Self-induction of abortion among women in the United States

Dealing with Breast Cancer

Mortality of induced abortion, other outpatient surgical procedures, and common activities in the US

Knowledge of Abortion Laws and Services among Low-Income Women in Three United States Cities

Reaching women where they are

Off-label indications for mifepristone in gynecology and obstetrics

Two prophylactic medication approaches in addition to a pain control regimen for early MA

Dissemination and implementing a core outcome set for medical and surgical abortion

Sixteen Years of Overregulation: Time to Unburden Mifeprex

Habib, N.

Two prophylactic medication approaches in addition to a pain control regimen for early MA

Guilbert, E

Regimens of misoprostol with mifepristone for early medical abortion

Medical abortion

Haider, S.

Sexual violence-related pregnancies in eastern Democratic Republic of Congo

Hai, P. T.

Results from a study using misoprostol for management of incomplete abortion in Vietnamese hospitals

Haleb, D.

Self-administered multi-level pregnancy tests in simplified follow-up of medical abortion in Tunisia

Gynuity Health Projects

Map of Misoprostol Approvals

Route of Misoprostol Administration

FAQs on Fatal Infection and Medical Abortion - Summary

FAQs on Fatal Infection and Medical Abortion - Technical Version

Outlook Newsletter on Hormonal Contraception and HIV

Issue Brief on Hormonal Contraception and HIV

FAQ on Hormonal Contraception and HIV

Relationship of Hormonal Contraception to HIV

PAC in Action Newsletter: Special Issue on Misoprostol in the PAC Context

Misoprostol: A New Addition to Post Abortion Care

Postpartum hemorrhage: Moving from Research to Reality

Postpartum Hemorrhage: A Challenge for Safe Motherhood

Misoprostol for prevention of postpartum hemorrhage

List of Mifepristone Approvals

Map of Mifepristone Approvals

Misoprostol and Teratogenicity: Reviewing the Evidence

Misoprostol for Early Abortion

Training and Education Activities Brief

Misoprostol for Incomplete Abortion and Miscarriage

Research

Medical Abortion Program Brief

Postpartum hemorrhage

Pregnancy Failure and Miscarriage Program Brief

Materials Development Activities Brief

Policy and Advocacy Activities Brief

Social Science Research Activities Brief

Technical Assistance Activities Brief

Infectious Disease Program Brief

Blood Loss After Vaginal Delivery

Fever after treatment of postpartum hemorrhage

Expanding Choice in Abortion Services in Armenia

Choices for Medical Abortion Introduction in Brazil, Colombia, Mexico and Peru

Improving Current Therapies and Exploring New Options in Abortifacient Technology

Abortion in the Middle East and North Africa

Misoprostol for the Prevention of Postpartum Hemorrhage: Findings from Research in Pakistan

Misoprostol for the Treatment of Postpartum Hemorrhage: Findings from Clinical Research Trials

Medical Abortion Guidebook

Guidebook on Misoprostol for Treatment of Incomplete Abortion

Home administration of misoprostol for early medical abortion in India

Misoprostol, Abortion, and the Law

Abortion With Self-Administered Misoprostol: A Guide For Women

Misoprostol for Treatment of Postpartum Hemorrhage

Hajri, Selma

Comparison of regimens for home-based early medical abortion in Tunisia and Vietnam

A double-blind randomized controlled trial of mifepristone or placebo before buccal misoprostol

A two-pill sublingual misoprostol outpatient regimen following mife for MA through 70 days' LMP

Self-administered multi-level pregnancy tests in simplified follow-up of medical abortion in Tunisia

Hannaford, P.

Hormonal contraceptive methods and risk of HIV acquisition in women

Halpern, Vera

Pericoital Oral Contraception with Levonorgestrel: A Systematic Review

Evaluation of efficacy, safety & acceptability of pericoital oral contraception with levonorgestrel

Spermicide used alone for contraception

A single-arm study to evaluate the efficacy, safety and acceptability of pericoital oral contracept

Hann, Louisa

Use of sequential serum hCG and sonography for medical abortion only when indicated

Hassairi, A. E.

Self-administered multi-level pregnancy tests in simplified follow-up of medical abortion in Tunisia

Harries, Jane

Perspectives on reproductive decision-making amongst HIV-infected individuals

Reproductive intentions among HIV-positive women and men

Hassane, Cisse

Oral misoprostol as first-line care for incomplete abortion in Burkina Faso

Harrison, T

Integrating medical abortion into safe abortion services in South Africa

Hassoun, Danielle

Introduction and provision of medical abortion: A tale of two countries

Hatcher, Juanita

Administration of misoprostol by trained TBAs to prevent PPH in homebirths in Pakistan

Haycox, Alan

Foley catheterisation versus oral misoprostol for induction of labour in hypertensive women in India

Hatcher, R. A.

Progestin-only Pills

Contraceptive Implants

Hassanein, Nevine

Sublingual misoprostol vs. MVA for the treatment of incomplete abortion in Egypt

Ho, P. C.

Misoprostol to treat missed abortion in the first trimester

Treatment of incomplete abortion and miscarriage with misoprostol

Holt, Kelsey

Self-induction of abortion among women in the United States

Knowledge of Abortion Laws and Services among Low-Income Women in Three United States Cities

Hofmeyr, Justus

Misoprostol: adjunct treatment to standard uterotonics for treatment of PPH

Misoprostol to augment routine active management of the third stage of labor

Huong, N, M.

Two prophylactic medication approaches in addition to a pain control regimen for early MA

Hyland, P

Increasing Access to Abortion With Telemedicine

Howe, Michelle

Two distinct oral routes of misoprostol in mifepristone medical abortion

Medical abortion: Outcomes in a family medicine setting

Ibis Reproductive Health

Issue Brief on Hormonal Contraception and HIV

Islam, N

Acceptability and Feasibility of Mifepristone-Misoprostol For Menstrual Regulation in Bangladesh

Jacot, F

Regimens of misoprostol with mifepristone for early medical abortion

Jamshidi, R.

Effects of Depot Medroxyprogesterone Acetate Injection Timing on MA Efficacy and Repeat Pregnancy

Jahan, Nusrat

Administration of misoprostol by trained TBAs to prevent PPH in homebirths in Pakistan

Johnston, H. B.

Acceptability and Feasibility of Mifepristone-Misoprostol For Menstrual Regulation in Bangladesh

Kalams, S. A.

800μg misoprostol and mucosal and systemic immune activation or the cervicovaginal microbiome

Jymagylova, D

Mifepristone-Misoprostol for early Medical Abortion in Uzbekistan

Kalumuna, R

Misoprostol for incomplete abortion in Tanzania

Kaplan, C.

Effects of Depot Medroxyprogesterone Acetate Injection Timing on MA Efficacy and Repeat Pregnancy

Kamilov, A

Mifepristone-Misoprostol for early Medical Abortion in Uzbekistan

Kapp, Nathalie

Alternatives to mifepristone for early medical abortion

Two prophylactic medication approaches in addition to a pain control regimen for early MA

Karki, Chanda

Acceptability and feasibility of medical abortion in Nepal

A prospective open-label study of home use of mifepristone for medical abortion in Nepal

Kasimova, F

Mifepristone-Misoprostol for early Medical Abortion in Uzbekistan

Kati, Kreston

Mifepristone medical abortion in Albania

Kawonga, M

Integrating medical abortion into safe abortion services in South Africa

Kim, C.R.

Dissemination and implementing a core outcome set for medical and surgical abortion

Khedekar, Vaishali

Treatment approaches for preeclampsia in low-resource settings

Foley catheterisation versus oral misoprostol for induction of labour in hypertensive women in India

Kipingili, R

Misoprostol for incomplete abortion in Tanzania

Koenig, L

Self-administered multi-level pregnancy tests in simplified follow-up of medical abortion in Tunisia

Kiran, Sibel

Increasing women's choices in medical abortion in Turkey

Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone

Kowal, D

Progestin-only Pills

Contraceptive Implants

Krishna, Usha

Are two doses of misoprostol after mifepristone for early abortion better than one?

Kurbanbekova, D

Mifepristone-Misoprostol for early Medical Abortion in Uzbekistan

Phone follow-up with SQPT after medical abortion in Moldova and Uzbekistan

Labassi, H

Self-administered multi-level pregnancy tests in simplified follow-up of medical abortion in Tunisia

Kushwaha, Anu

Acceptability and feasibility of medical abortion in Nepal

Lankoande, Jean

Misoprostol for incomplete abortion in Burkina Faso

Oral misoprostol as first-line care for incomplete abortion in Burkina Faso

Lara, Diana

Self-induction of abortion among women in the United States

Knowledge of Abortion Laws and Services among Low-Income Women in Three United States Cities

Leigh, S.

Foley catheterisation versus oral misoprostol for induction of labour in hypertensive women in India

León, Wilfrido

Sublingual misoprostol vs oxytocin in women not exposed to oxytocin during labor

High fever following postpartum administration of sublingual misoprostol

Oral Misoprostol for the Management of Incomplete Abortion in Ecuador

Dose and side effects of sublingual misoprostol for treatment of postpartum hemorrhage

Misoprostol-induced fever and genetic polymorphisms in drug transporters

Lendvay, Anja

Exploration of a new procedure for sterilization

Evaluation of efficacy, safety & acceptability of pericoital oral contraception with levonorgestrel

A single-arm study to evaluate the efficacy, safety and acceptability of pericoital oral contracept

Lichtenberg, Steve

Alternatives to Routine Follow-Up for Early Medical Abortion

At-home semi-quantitative pregnancy tests as replacement for clinical follow-up of medical abortion

Outpatient medical abortion through 70 days

Prophylactic compared with therapeutic Ibuprofen analgesia in first-trimester medical abortion

Cervical Preparation Before Dilation and Evacuation Using Adjunctive Misoprostol or Mifepristone

Alternatives to routine ultrasound for eligibility assessment prior to medical abortion

Loc, Ly Thai

Results of a pilot study in the U.S. and Vietnam to assess the utility and acceptability of a MLPT

Lishchuk, V

Efficacy and acceptability of early mifepristone-misoprostol medical abortion in Ukraine

Lotarevich, T

Prospective study of home use of mifepristone and misoprostol for medical abortion up to 10weeks

Home use of mifepristone and misoprostol for MA up to 10weeks of pregnancy in Kazakhstan

Mifepristone–misoprostol for menstrual regulation in public sector facilities in Bangladesh

Lopez, Laureen M

Pericoital Oral Contraception with Levonorgestrel: A Systematic Review

Progestin-only pills for contraception

Spermicide used alone for contraception

Lugo-Hernández, E. M.

Effects of Depot Medroxyprogesterone Acetate Injection Timing on MA Efficacy and Repeat Pregnancy

Louie, K. S.

Prophylactic compared with therapeutic Ibuprofen analgesia in first-trimester medical abortion

Acceptability and feasibility of mifepristone medical abortion in the early first trimester in Azerb

The introduction of first trimester medical abortion in Armenia

Effects of Depot Medroxyprogesterone Acetate Injection Timing on MA Efficacy and Repeat Pregnancy

Second trimester MA with mifepristone followed by unlimited dosing of buccal misoprostol in Armenia

Acceptability & feasibility of 400μg buccal misoprostol after 200 mg mife for early MA in Georgia

Lumbiganon, Pisake

Misoprostol: adjunct treatment to standard uterotonics for treatment of PPH

Lynd, Kelsey

At-home semi-quantitative pregnancy tests as replacement for clinical follow-up of medical abortion

Simplified medical abortion using a semi-quantitative pregnancy test for home-based follow-up

Acceptability and feasibility of phone follow-up after early medical abortion in Vietnam

Maistruk, G

Efficacy and acceptability of early mifepristone-misoprostol medical abortion in Ukraine

Manandhar, Durga

Acceptability and feasibility of medical abortion in Nepal

Mandlekar, Ajita

Are two doses of misoprostol after mifepristone for early abortion better than one?

Mangesi, Lindeka

Misoprostol to augment routine active management of the third stage of labor

Martínez, M. L.

Efficacy and acceptability of a mifepristone-misoprostol combined regimen for early induced abortion

Martin, R

Determining early medical abortion outcomes at 3, 7 and 14 days after mifepristone

Simultaneous Administration Compared With a 24-Hour Mifepristone-Misoprostol Interval

Manoku, Nikita

Mifepristone medical abortion in Albania

Maurer, R

Cervical Preparation Before Dilation and Evacuation Using Adjunctive Misoprostol or Mifepristone

Mashaka, N

Misoprostol for incomplete abortion in Tanzania

Mayi-Tsonga, Sosthène

First experience of the use of misoprostol as post-abortion care in Libreville, Gabon.

Mbila, Arielle

First experience of the use of misoprostol as post-abortion care in Libreville, Gabon.

McKetta, S

Cervical Preparation Before Dilation and Evacuation Using Adjunctive Misoprostol or Mifepristone

Meckstroth, K

Claims of misoprostol use based on blood sampling should be viewed with skepticism

Mavimbela, N

Assessment of pregnancy duration among termination of pregnancy clients in South Africa

Memmel, L.

Effects of Depot Medroxyprogesterone Acetate Injection Timing on MA Efficacy and Repeat Pregnancy

Mendoza, L. J.

Efficacy and acceptability of a mifepristone-misoprostol combined regimen for early induced abortion

Medhat, Ibrahim

Sublingual misoprostol vs oxytocin in women not exposed to oxytocin during labor

Middleton, Tamer

Acceptability of home use of mifepristone for medical abortion

Milne, G

800μg misoprostol and mucosal and systemic immune activation or the cervicovaginal microbiome

Mignini, Luciano

Misoprostol: adjunct treatment to standard uterotonics for treatment of PPH

Minkobame, Ulysse

First experience of the use of misoprostol as post-abortion care in Libreville, Gabon.

Mirembe, Florence M

Preventing postpartum hemorrhage at the community level

The MamaMiso study of self-administered misoprostol to prevent bleeding after childbirth in Uganda

Minh, Nguyen Thi Hong

Mifepristone and Misoprostol Compared With Misoprostol Alone for Second-trimester Abortion

Acceptability and feasibility of phone follow-up after early medical abortion in Vietnam

Mitra, S. N.

Community-based kangaroo mother care to prevent neonatal and infant mortality

Mobeen, Naushaba

Administration of misoprostol by trained TBAs to prevent PPH in homebirths in Pakistan

Moisiu, Rubena

Mifepristone medical abortion in Albania

Montesinos, Rolando

Oral Misoprostol for the Management of Incomplete Abortion in Ecuador

Moore, K

Embracing post-fertilisation methods of family planning: a call to action

Morison, B.

Misoprostol in the management of the third stage of labour in the home delivery in Gambia

Moreno-Ruiz, Nilda

Alternatives to mifepristone for early medical abortion

Mousa, H. A.

Treatment for primary postpartum haemorrhage

Moskowitz, Jeffrey

Two distinct oral routes of misoprostol in mifepristone medical abortion

Mulik, J.

Foley catheterisation versus oral misoprostol for induction of labour in hypertensive women in India

Mugerwa, Kidza

Misoprostol to augment routine active management of the third stage of labor

Murray, M.È.

Medical abortion

Murtagh, C

Study finds that obtaining abortion pills from the internet is feasible in the US

Mundle, Shuchita

Treatment approaches for preeclampsia in low-resource settings

Facility and personnel factors influencing magnesium sulfate use for eclampsia and preeclampsia

A two-pill sublingual misoprostol outpatient regimen following mife for MA through 70 days' LMP

Foley catheterisation versus oral misoprostol for induction of labour in hypertensive women in India

Nanda, K

Spermicide used alone for contraception

Myer, Landon

Perspectives on reproductive decision-making amongst HIV-infected individuals

Reproductive intentions among HIV-positive women and men

Nayama, Madi

Incomplete abortion in five sub-Saharan African countries

Nelson, A

Progestin-only Pills

Contraceptive Implants

Nga, Nguyen Thi Bach

Comparing two early medical abortion regimens: Mifepristone+misoprostol vs. misoprostol alone

Mifepristone and Misoprostol Compared With Misoprostol Alone for Second-trimester Abortion

Acceptability and feasibility of phone follow-up after early medical abortion in Vietnam

Determining early medical abortion outcomes at 3, 7 and 14 days after mifepristone

Simultaneous Administration Compared With a 24-Hour Mifepristone-Misoprostol Interval

Ngoc, Nguyen Thi Nhu

Mifepristone for late first trimester abortion

Sublingual misoprostol vs oxytocin in women not exposed to oxytocin during labor

Sublingual misoprostol vs oxytocin in women receiving prophylactic oxytocin

Misoprostol: adjunct treatment to standard uterotonics for treatment of PPH

Comparing two early medical abortion regimens: Mifepristone+misoprostol vs. misoprostol alone

Mifepristone and Misoprostol Compared With Misoprostol Alone for Second-trimester Abortion

Two doses of buccal misoprostol following mifepristone

Comparison of regimens for home-based early medical abortion in Tunisia and Vietnam

Clinic-level introduction of medical abortion in Vietnam

Simplified medical abortion using a semi-quantitative pregnancy test for home-based follow-up

Results from a study using misoprostol for management of incomplete abortion in Vietnamese hospitals

Acceptability and feasibility of phone follow-up after early medical abortion in Vietnam

Buccal misoprostol for IUFD Research Group

Determining early medical abortion outcomes at 3, 7 and 14 days after mifepristone

Simultaneous Administration Compared With a 24-Hour Mifepristone-Misoprostol Interval

Serial Multilevel Urine Pregnancy Testing to Assess Medical Abortion Outcome

Results of a pilot study in the U.S. and Vietnam to assess the utility and acceptability of a MLPT

Nhan, T. T.

Results from a study using misoprostol for management of incomplete abortion in Vietnamese hospitals

Norman, W.V.

Medical abortion

Nidadavolu, Vijaya

Abortion and sex determination

Okonofua, F

Acceptability and feasibility of medical abortion with mifepristone and misoprostol in Nigeria

Oladapo, O.T.

Advance misoprostol distribution for preventing and treating postpartum haemorrhage

Olayinka, Ogunbode

Incomplete abortion in five sub-Saharan African countries

Ononge, Sam

Preventing postpartum hemorrhage at the community level

The MamaMiso study of self-administered misoprostol to prevent bleeding after childbirth in Uganda

Achieving community-based postpartum follow up in eastern Uganda

Onyango, M. A.

Sexual violence-related pregnancies in eastern Democratic Republic of Congo

Orner, Phyllis

Perspectives on reproductive decision-making amongst HIV-infected individuals

Reproductive intentions among HIV-positive women and men

Ouattara, Adama Z

Oral misoprostol as first-line care for incomplete abortion in Burkina Faso

Ouedraego, Mimi

Misoprostol for incomplete abortion in Burkina Faso

Owen, A

Misoprostol-induced fever and genetic polymorphisms in drug transporters

Panton, Tanya

Use of sequential serum hCG and sonography for medical abortion only when indicated

Patel, A

Buccal misoprostol for IUFD Research Group

Path

Outlook Newsletter on Hormonal Contraception and HIV

Peña, Melanie

Self-induction of abortion among women in the United States

Oral Misoprostol for the Management of Incomplete Abortion in Ecuador

Medical abortion: A path to safe, high-quality abortion care in Latin America and the Caribbean

Efficacy and acceptability of a mifepristone-misoprostol combined regimen for early induced abortion

Safety, efficacy and acceptability of outpatient mifepristone-misoprostol MA through 70 days

Knowledge of Abortion Laws and Services among Low-Income Women in Three United States Cities

Pendergast, M.K.

Sixteen Years of Overregulation: Time to Unburden Mifeprex

Phan, Van Quy

Mifepristone and Misoprostol Compared With Misoprostol Alone for Second-trimester Abortion

Philip, Neena

Misoprostol and Teratogenicity: Reviewing the Evidence

Phillips, S. J.

Hormonal contraceptive methods and risk of HIV acquisition in women

Pinto, Ernesto

Oral Misoprostol for the Management of Incomplete Abortion in Ecuador

Dose and side effects of sublingual misoprostol for treatment of postpartum hemorrhage

Pirmohamed, M

Misoprostol-induced fever and genetic polymorphisms in drug transporters

Platais, Ingrida

Armenia: A Way to Make Abortion Safer

A two-pill sublingual misoprostol outpatient regimen following mife for MA through 70 days' LMP

Phone follow-up with SQPT after medical abortion in Moldova and Uzbekistan

Prospective study of home use of mifepristone and misoprostol for medical abortion up to 10weeks

Home use of mifepristone and misoprostol for MA up to 10weeks of pregnancy in Kazakhstan

Serial Multilevel Urine Pregnancy Testing to Assess Medical Abortion Outcome

Pokharel, Hanoon

Acceptability and feasibility of medical abortion in Nepal

Polanco, R. R.

Efficacy and acceptability of a mifepristone-misoprostol combined regimen for early induced abortion

Policar, M

Contraceptive Implants

Progestin-only Pills

Polis, C. B.

Cost-effectiveness of increased access to emergency contraceptive pills: probably not.

Hormonal contraceptive methods and risk of HIV acquisition in women

Population Council

Misoprostol for Women's Health

Misoprostol and Teratogenicity: Reviewing the Evidence

Population Reference Bureau

Abortion in the Middle East and North Africa

Porsch, L

Prophylactic compared with therapeutic Ibuprofen analgesia in first-trimester medical abortion

Posohova, S

Efficacy and acceptability of early mifepristone-misoprostol medical abortion in Ukraine

A two-pill sublingual misoprostol outpatient regimen following mife for MA through 70 days' LMP

Postabortion Care Consortium

PAC in Action Newsletter: Special Issue on Misoprostol in the PAC Context

Prashad, N

800μg misoprostol and mucosal and systemic immune activation or the cervicovaginal microbiome

Prine, Linda

Two distinct oral routes of misoprostol in mifepristone medical abortion

Medical abortion: Outcomes in a family medicine setting

Acceptability of home use of mifepristone for medical abortion

Pymar, H.

Medical abortion

Raghavan, Sheila

Misoprostol for incomplete abortion in Burkina Faso

Sublingual misoprostol after mifepristone

Sublingual misoprostol for incomplete abortion

Guidebook on Misoprostol for Treatment of Incomplete Abortion

Sublingual misoprostol vs oxytocin in women not exposed to oxytocin during labor

Sublingual misoprostol vs oxytocin in women receiving prophylactic oxytocin

Buccal vs. sublingual misoprostol after mifepristone for medical abortion

Comparing two early medical abortion regimens: Mifepristone+misoprostol vs. misoprostol alone

A double-blind randomized controlled trial of mifepristone or placebo before buccal misoprostol

Mifepristone and Misoprostol Compared With Misoprostol Alone for Second-trimester Abortion

Review of the Literature on Patient Satisfaction with Early Medical Abortion

Comparison of regimens for home-based early medical abortion in Tunisia and Vietnam

Clinic-level introduction of medical abortion in Vietnam

Misoprostol for the management of postpartum bleeding: A new approach

Mifepristone-Misoprostol for early Medical Abortion in Uzbekistan

Efficacy and acceptability of early mifepristone-misoprostol medical abortion in Ukraine

Acceptability and Feasibility of Mifepristone-Misoprostol For Menstrual Regulation in Bangladesh

Misoprostol for prevention and treatment of postpartum hemorrhage: What do we know? What is next?

Rajbhandari, S.P.

Rakotovao, Jean-Pierre

Sublingual misoprostol for incomplete abortion

Ramchandani, Parvati

Exploration of a new procedure for sterilization

Raote, Veena

Are two doses of misoprostol after mifepristone for early abortion better than one?

Raymond, Elizabeth G

Pericoital Oral Contraception with Levonorgestrel: A Systematic Review

Exploration of a new procedure for sterilization

Medical abortion for adolescents

First-trimester medical abortion with mifepristone 200 mg and misoprostol: A systematic review

Feticidal digoxin before D&E

The comparative safety of legal induced abortion and childbirth in the United States

Combined hormonal contraceptives and venous thromboembolism

Evaluation of efficacy, safety & acceptability of pericoital oral contraception with levonorgestrel

Estimating contraceptive efficacy: the case of spermicides

Cost-effectiveness of increased access to emergency contraceptive pills: probably not.

Prophylactic compared with therapeutic Ibuprofen analgesia in first-trimester medical abortion

Progestin-only Pills

Contraceptive Implants

Embracing post-fertilisation methods of family planning: a call to action

Dealing with Breast Cancer

Progestin-only pills for contraception

Spermicide used alone for contraception

A single-arm study to evaluate the efficacy, safety and acceptability of pericoital oral contracept

Emergency Contraception: A Last Chance to Prevent Unintended Pregnancy

Mortality of induced abortion, other outpatient surgical procedures, and common activities in the US

Hormonal contraceptive methods and risk of HIV acquisition in women

Reaching women where they are

Outpatient medical abortion is safe and effective through 70 days gestation

Early Medical Abortion without Prior Ultrasound

Increasing Access to Abortion With Telemedicine

Effects of Depot Medroxyprogesterone Acetate Injection Timing on MA Efficacy and Repeat Pregnancy

Serial Multilevel Urine Pregnancy Testing to Assess Medical Abortion Outcome

Letter to the editor on Emergency Contraception

Sixteen Years of Overregulation: Time to Unburden Mifeprex

What some women want? On-demand oral contraception

Study finds that obtaining abortion pills from the internet is feasible in the US

Rädisch, S

Misoprostol-induced fever and genetic polymorphisms in drug transporters

Reeves, Matthew F

Estimating contraceptive efficacy: the case of spermicides

Medical abortion

Regi, Annie

Treatment approaches for preeclampsia in low-resource settings

Regmi, K.

Reichenbach, L

Acceptability and Feasibility of Mifepristone-Misoprostol For Menstrual Regulation in Bangladesh

Mifepristone–misoprostol for menstrual regulation in public sector facilities in Bangladesh

Reproductive Health Technologies Project

FAQs on Fatal Infection and Medical Abortion - Summary

Issue Brief on Hormonal Contraception and HIV

Misoprostol for Early Abortion

Misoprostol for Incomplete Abortion and Miscarriage

Misoprostol, Abortion, and the Law

Ro, U

Community-based kangaroo mother care to prevent neonatal and infant mortality

Rogers, L. M.

800μg misoprostol and mucosal and systemic immune activation or the cervicovaginal microbiome

Roudi-Fahimi, Farzaneh

Abortion in the Middle East and North Africa

Rouhani, S.

Sexual violence-related pregnancies in eastern Democratic Republic of Congo

Rybczyk, K

800μg misoprostol and mucosal and systemic immune activation or the cervicovaginal microbiome

Rzayeva, G

Acceptability and feasibility of mifepristone medical abortion in the early first trimester in Azerb

Sacks, Daniel

Outpatient medical abortion through 70 days

Sanhueza Smith, P

Safety, efficacy and acceptability of outpatient mifepristone-misoprostol MA through 70 days

Effects of Depot Medroxyprogesterone Acetate Injection Timing on MA Efficacy and Repeat Pregnancy

Schaff, Eric

Mifepristone for late first trimester abortion

Schiavon, Raffaela

Treatment of incomplete abortion and miscarriage with misoprostol

Schreiber, Courtney A

Acceptability of home use of mifepristone for medical abortion

Off-label indications for mifepristone in gynecology and obstetrics

Schulz, K. F.

Spermicide used alone for contraception

Shochet, Tara

Mifepristone and Misoprostol Compared With Misoprostol Alone for Second-trimester Abortion

At-home semi-quantitative pregnancy tests as replacement for clinical follow-up of medical abortion

Clinic-level introduction of medical abortion in Vietnam

Incomplete abortion in five sub-Saharan African countries

Efficacy and acceptability of early mifepristone-misoprostol medical abortion in Ukraine

Serial Multilevel Urine Pregnancy Testing to Assess Medical Abortion Outcome

Scott, J

Sexual violence-related pregnancies in eastern Democratic Republic of Congo

Sfar, E

Self-administered multi-level pregnancy tests in simplified follow-up of medical abortion in Tunisia

Shah, M

A two-pill sublingual misoprostol outpatient regimen following mife for MA through 70 days' LMP

Shakur, H.

Treatment for primary postpartum haemorrhage

Shamsuddin, Nadia

Schweikert, Suzanne

Alternatives to Routine Follow-Up for Early Medical Abortion

Alternatives to routine ultrasound for eligibility assessment prior to medical abortion

Shannon, Caitlin

Misoprostol for Women's Health

Misoprostol and Teratogenicity: Reviewing the Evidence

Supervision for use of mifepristone medical abortion

Misoprostol for uterine evacuation in induced abortion and pregnancy failure

Two distinct oral routes of misoprostol in mifepristone medical abortion

Comment on Misoprostol impairs female reproductive tract innate immunity against C. sordellii

Regimens of misoprostol with mifepristone for early medical abortion

Mifepristone medical abortion in Albania

Unsafe Abortion and Strategies to Reduce its Impact on Women’s Lives

Medical abortion: Outcomes in a family medicine setting

First-trimester medical abortion with mifepristone 200 mg and misoprostol: A systematic review

Shekhavat, D. Ratna

Treatment approaches for preeclampsia in low-resource settings

Shaunik, Alka

Exploration of a new procedure for sterilization

Shittu, O

Acceptability and feasibility of medical abortion with mifepristone and misoprostol in Nigeria

Shochet, T

A double-blind randomized controlled trial of mifepristone or placebo before buccal misoprostol

Simplified medical abortion using a semi-quantitative pregnancy test for home-based follow-up

Social marketing of emergency contraception: Are we missing a valuable opportunity?

Results from a study using misoprostol for management of incomplete abortion in Vietnamese hospitals

Acceptability and feasibility of medical abortion with mifepristone and misoprostol in Nigeria

Decentralizing postabortion care in Senegal with misoprostol for incomplete abortion

Calibrated delivery drape versus indirect gravimetric technique for the measurement of blood loss

Safety, efficacy and acceptability of outpatient mifepristone-misoprostol MA through 70 days

Self-administered multi-level pregnancy tests in simplified follow-up of medical abortion in Tunisia

Results of a pilot study in the U.S. and Vietnam to assess the utility and acceptability of a MLPT

What some women want? On-demand oral contraception

Sheldon, Wendy R

Regimens of misoprostol with mifepristone for early medical abortion

Misoprostol for the prevention and treatment of postpartum hemorrhage

Use of Medicines Changing the Face of Abortion

Controlled cord traction in active management of the third stage of labour (comment)

Abortion: What is the problem?

WHO Multicountry Survey on Maternal and Newborn Health Research Network

How effective are the components of active management of the third stage of labor?

Mifepristone label laws and trends in use: recent experiences in four US states

Determining early medical abortion outcomes at 3, 7 and 14 days after mifepristone

Serial Multilevel Urine Pregnancy Testing to Assess Medical Abortion Outcome

Results of a pilot study in the U.S. and Vietnam to assess the utility and acceptability of a MLPT

Shwekerela, B

Misoprostol for incomplete abortion in Tanzania

Siccardi, M

Misoprostol-induced fever and genetic polymorphisms in drug transporters

Sikander, Rozina

Misoprostol in addition to routine treatment of postpartum hemorrhage in Pakistan

Singata, Mandisa

Misoprostol: adjunct treatment to standard uterotonics for treatment of PPH

Misoprostol to augment routine active management of the third stage of labor

Sloan, Nancy

Community-based kangaroo mother care to prevent neonatal and infant mortality

Oxytocin via Uniject versus oral misoprostol for prevention of postpartum haemorrhage

Misoprostol in the management of the third stage of labour in the home delivery in Gambia

Smith, P. S.

Efficacy and acceptability of a mifepristone-misoprostol combined regimen for early induced abortion

Smith, R. M.

800μg misoprostol and mucosal and systemic immune activation or the cervicovaginal microbiome

Sokal, David

Exploration of a new procedure for sterilization

Sonalkar, S.

Effects of Depot Medroxyprogesterone Acetate Injection Timing on MA Efficacy and Repeat Pregnancy

Soon, J.

Medical abortion

Souza, J

WHO Multicountry Survey on Maternal and Newborn Health Research Network

Sow, M

Oxytocin via Uniject versus oral misoprostol for prevention of postpartum haemorrhage

Sowe, L.

Misoprostol in the management of the third stage of labour in the home delivery in Gambia

Starrs, Ann

Misoprostol for postpartum hemorrhage: Moving from evidence to practice

Steyn, P. S.

Hormonal contraceptive methods and risk of HIV acquisition in women

Stuart, Gretchen S

Feticidal digoxin before D&E

Sumner, S

800μg misoprostol and mucosal and systemic immune activation or the cervicovaginal microbiome

Swica, Yael

Modern Methods of Abortion

Non-physician clinicians can safely provide first trimester medical abortion

Comparison of serum markers for thrombophilia and autoimmune disease

Review of the Literature on Patient Satisfaction with Early Medical Abortion

Acceptability of home use of mifepristone for medical abortion

Outpatient medical abortion through 70 days

Tamang, A.

Two prophylactic medication approaches in addition to a pain control regimen for early MA

Tan, Y. L.

Effects of Depot Medroxyprogesterone Acetate Injection Timing on MA Efficacy and Repeat Pregnancy

Tanenhaus, Jini

Alternatives to Routine Follow-Up for Early Medical Abortion

Alternatives to routine ultrasound for eligibility assessment prior to medical abortion

Tare, Vjollca

Mifepristone medical abortion in Albania

Tasha, Ilir

Mifepristone medical abortion in Albania

Taylor, D

Evaluation of efficacy, safety & acceptability of pericoital oral contraception with levonorgestrel

A single-arm study to evaluate the efficacy, safety and acceptability of pericoital oral contracept

Taylor, Joseph

Oral misoprostol as an alternative to surgical management for incomplete abortion in Ghana

Temimi, F

Self-administered multi-level pregnancy tests in simplified follow-up of medical abortion in Tunisia

Thach, Tran Son

Misoprostol: adjunct treatment to standard uterotonics for treatment of PPH

Thieba, Blandine

Misoprostol for incomplete abortion in Burkina Faso

Thinkhamrop, Jadsada

Misoprostol: adjunct treatment to standard uterotonics for treatment of PPH

Toti, S

Mortality of induced abortion, other outpatient surgical procedures, and common activities in the US

Trouton, K.

Medical abortion

Trussell, James

Estimating contraceptive efficacy: the case of spermicides

Cost-effectiveness of increased access to emergency contraceptive pills: probably not.

Progestin-only Pills

Contraceptive Implants

Embracing post-fertilisation methods of family planning: a call to action

Emergency Contraception: A Last Chance to Prevent Unintended Pregnancy

How effective are the components of active management of the third stage of labor?

Letter to the editor on Emergency Contraception

Tsereteli, Tamuna

Knowledge, attitudes, and practice of abortion among women and doctors in Armenia

Two doses of buccal misoprostol following mifepristone

Mifepristone-Misoprostol for early Medical Abortion in Uzbekistan

A two-pill sublingual misoprostol outpatient regimen following mife for MA through 70 days' LMP

Acceptability and feasibility of mifepristone medical abortion in the early first trimester in Azerb

The introduction of first trimester medical abortion in Armenia

Phone follow-up with SQPT after medical abortion in Moldova and Uzbekistan

Prospective study of home use of mifepristone and misoprostol for medical abortion up to 10weeks

Home use of mifepristone and misoprostol for MA up to 10weeks of pregnancy in Kazakhstan

Second trimester MA with mifepristone followed by unlimited dosing of buccal misoprostol in Armenia

Acceptability & feasibility of 400μg buccal misoprostol after 200 mg mife for early MA in Georgia

Tsertsvadze, G

A two-pill sublingual misoprostol outpatient regimen following mife for MA through 70 days' LMP

Tuladhar, H

A prospective open-label study of home use of mifepristone for medical abortion in Nepal

Turcanu, Steliana

Buccal vs. sublingual misoprostol after mifepristone for medical abortion

Turner, A. Mark

Foley catheterisation versus oral misoprostol for induction of labour in hypertensive women in India

Turner, A. N.

Hormonal contraceptive methods and risk of HIV acquisition in women

Ungureanu, Sergiu

Sublingual misoprostol after mifepristone

Buccal vs. sublingual misoprostol after mifepristone for medical abortion

Upreti, S.R.

Usta, Muhammad

Misoprostol for incomplete abortion in Mozambique

Van Bogaert, L. J.

Assessment of pregnancy duration among termination of pregnancy clients in South Africa

Van Nhang, N

Acceptability and feasibility of phone follow-up after early medical abortion in Vietnam

Van Thanh, L

Determining early medical abortion outcomes at 3, 7 and 14 days after mifepristone

VanRooyen, M.

Sexual violence-related pregnancies in eastern Democratic Republic of Congo

Vardanyan, Susanna

Knowledge, attitudes, and practice of abortion among women and doctors in Armenia

Home administration of misoprostol for early medical abortion in India

The introduction of first trimester medical abortion in Armenia

Veatch, Maggie

Self-induction of abortion among women in the United States

Villalón, A. E.

Efficacy and acceptability of a mifepristone-misoprostol combined regimen for early induced abortion

Vogel, J

WHO Multicountry Survey on Maternal and Newborn Health Research Network

Von Mollendorf, Claire

Assessment of pregnancy duration among termination of pregnancy clients in South Africa

Integrating medical abortion into safe abortion services in South Africa

Wagner, M.S.

Medical abortion

Waite, Clare

What Is the Most Effective, Low-Cost Method for Inducing Labor in Women With Pre-Eclampsia?

Walraven, Gijs

Prevention of postpartum hemorrhage with misoprostol

Treatment of postpartum hemorrhage with misoprostol

Misoprostol in addition to routine treatment of postpartum hemorrhage in Pakistan

Administration of misoprostol by trained TBAs to prevent PPH in homebirths in Pakistan

Misoprostol in the management of the third stage of labour in the home delivery in Gambia

Wasim, Saba

Administration of misoprostol by trained TBAs to prevent PPH in homebirths in Pakistan

Weaver, Mark A

First-trimester medical abortion with mifepristone 200 mg and misoprostol: A systematic review

Estimating contraceptive efficacy: the case of spermicides

Prophylactic compared with therapeutic Ibuprofen analgesia in first-trimester medical abortion

Mortality of induced abortion, other outpatient surgical procedures, and common activities in the US

Effects of Depot Medroxyprogesterone Acetate Injection Timing on MA Efficacy and Repeat Pregnancy

Serial Multilevel Urine Pregnancy Testing to Assess Medical Abortion Outcome

Weeks, Andrew

Misoprostol to treat missed abortion in the first trimester

Treatment of incomplete abortion and miscarriage with misoprostol

Prevention of postpartum hemorrhage with misoprostol

Treatment of postpartum hemorrhage with misoprostol

Preventing postpartum hemorrhage at the community level

The MamaMiso study of self-administered misoprostol to prevent bleeding after childbirth in Uganda

Misoprostol-induced fever and genetic polymorphisms in drug transporters

Foley catheterisation versus oral misoprostol for induction of labour in hypertensive women in India

Achieving community-based postpartum follow up in eastern Uganda

Wells, E.

Study finds that obtaining abortion pills from the internet is feasible in the US

Westheimer, Emily

Mifepristone for late first trimester abortion

Misoprostol for incomplete abortion in Mozambique

Misoprostol for incomplete abortion in Tanzania

Misoprostol: A New Addition to Post Abortion Care

Westhoff, Carolyn

Comparison of serum markers for thrombophilia and autoimmune disease

DMPA and HIV: do we need a trial?

Fifteen years: looking back and looking forward

Sixteen Years of Overregulation: Time to Unburden Mifeprex

Westley, E

Social marketing of emergency contraception: Are we missing a valuable opportunity?

What some women want? On-demand oral contraception

Westphal, Lynn M.

Results of a pilot study in the U.S. and Vietnam to assess the utility and acceptability of a MLPT

Westreich, D. J.

Hormonal contraceptive methods and risk of HIV acquisition in women

Wheeless, A

A single-arm study to evaluate the efficacy, safety and acceptability of pericoital oral contracept

Whitehouse, K.C.

Dissemination and implementing a core outcome set for medical and surgical abortion

Widmer, Mariana

Misoprostol: adjunct treatment to standard uterotonics for treatment of PPH

Wiebe, Ellen

Alternatives to mifepristone for early medical abortion

Regimens of misoprostol with mifepristone for early medical abortion

Reaching women where they are

Medical abortion

Winikoff, Beverly

Are two doses of misoprostol after mifepristone for early abortion better than one?

Can mifepristone medical abortion be simplified?

Mifepristone for late first trimester abortion

Assessment of pregnancy duration among termination of pregnancy clients in South Africa

Methotrexate compared to misoprostol alone for early medical abortion

The supreme court and the partial-birth abortion ban act of 2003

Abortion is for women

Misoprostol for incomplete abortion in Mozambique

Misoprostol for incomplete abortion in Burkina Faso

Misoprostol for incomplete abortion in Tanzania

Misoprostol to treat missed abortion in the first trimester

Treatment of incomplete abortion and miscarriage with misoprostol

Prevention of postpartum hemorrhage with misoprostol

Treatment of postpartum hemorrhage with misoprostol

Misoprostol for Women's Health

Supervision for use of mifepristone medical abortion

Alternatives to mifepristone for early medical abortion

Misoprostol for uterine evacuation in induced abortion and pregnancy failure

A double-blind randomized controlled trial of mifepristone or placebo before buccal misoprostol

Two distinct oral routes of misoprostol in mifepristone medical abortion

Comment on Misoprostol impairs female reproductive tract innate immunity against C. sordellii

Integrating medical abortion into safe abortion services in South Africa

Early pregnancy termination

Clostridium sordellii infection in medical abortion

Regimens of misoprostol with mifepristone for early medical abortion

Mifepristone medical abortion in Albania

Misoprostol and Teratogenicity: Reviewing the Evidence

Sublingual misoprostol after mifepristone

Sublingual misoprostol for incomplete abortion

Increasing women's choices in medical abortion in Turkey

Non-physician clinicians can safely provide first trimester medical abortion

Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone

Knowledge, attitudes, and practice of abortion among women and doctors in Armenia

Acceptability and feasibility of medical abortion in Nepal

Sublingual misoprostol vs oxytocin in women not exposed to oxytocin during labor

Sublingual misoprostol vs oxytocin in women receiving prophylactic oxytocin

Alternatives to Routine Follow-Up for Early Medical Abortion

High fever following postpartum administration of sublingual misoprostol

What measured blood loss tells us about postpartum bleeding

Misoprostol: adjunct treatment to standard uterotonics for treatment of PPH

Unsafe Abortion and Strategies to Reduce its Impact on Women’s Lives

Sublingual misoprostol vs. MVA for the treatment of incomplete abortion in Egypt

Self-induction of abortion among women in the United States

Buccal vs. sublingual misoprostol after mifepristone for medical abortion

Oral misoprostol as an alternative to surgical management for incomplete abortion in Ghana

Comparing two early medical abortion regimens: Mifepristone+misoprostol vs. misoprostol alone

Introduction and provision of medical abortion: A tale of two countries

Mifepristone and Misoprostol Compared With Misoprostol Alone for Second-trimester Abortion

Review of the Literature on Patient Satisfaction with Early Medical Abortion

Oral Misoprostol for the Management of Incomplete Abortion in Ecuador

Misoprostol for the prevention and treatment of postpartum hemorrhage

Two doses of buccal misoprostol following mifepristone

Treatment approaches for preeclampsia in low-resource settings

Facility and personnel factors influencing magnesium sulfate use for eclampsia and preeclampsia

Misoprostol for postpartum hemorrhage: Moving from evidence to practice

Comparison of regimens for home-based early medical abortion in Tunisia and Vietnam

First-trimester medical abortion with mifepristone 200 mg and misoprostol: A systematic review

At-home semi-quantitative pregnancy tests as replacement for clinical follow-up of medical abortion

Clinic-level introduction of medical abortion in Vietnam

Misoprostol as first-line treatment for incomplete abortion in Nigeria

Misoprostol for the management of postpartum bleeding: A new approach

Use of Medicines Changing the Face of Abortion

Incomplete abortion in five sub-Saharan African countries

Acceptability of home use of mifepristone for medical abortion

Outpatient medical abortion through 70 days

Sublingual Misoprostol for the Treatment of Postpartum Hemorrhage

Medical abortion: A path to safe, high-quality abortion care in Latin America and the Caribbean

Dose and side effects of sublingual misoprostol for treatment of postpartum hemorrhage

Misoprostol for Treatment of Incomplete Abortion: A Training Guide

Controlled cord traction in active management of the third stage of labour (comment)

Mifepristone-Misoprostol for early Medical Abortion in Uzbekistan

Efficacy and acceptability of early mifepristone-misoprostol medical abortion in Ukraine

Simplified medical abortion using a semi-quantitative pregnancy test for home-based follow-up

A new formulation of misoprostol is unlikely to revolutionise postpartum haemorrhage care

Results from a study using misoprostol for management of incomplete abortion in Vietnamese hospitals

Acceptability and Feasibility of Mifepristone-Misoprostol For Menstrual Regulation in Bangladesh

Misoprostol for prevention and treatment of postpartum hemorrhage: What do we know? What is next?

Abortion: What is the problem?

Community-based kangaroo mother care to prevent neonatal and infant mortality

Embracing post-fertilisation methods of family planning: a call to action

A two-pill sublingual misoprostol outpatient regimen following mife for MA through 70 days' LMP

Acceptability and feasibility of phone follow-up after early medical abortion in Vietnam

Acceptability and feasibility of medical abortion with mifepristone and misoprostol in Nigeria

Buccal misoprostol for IUFD Research Group

Evidence versus influence in the WHO procedure for approving essential medicines

Efficacy and acceptability of a mifepristone-misoprostol combined regimen for early induced abortion

Decentralizing postabortion care in Senegal with misoprostol for incomplete abortion

Acceptability and feasibility of mifepristone medical abortion in the early first trimester in Azerb

First experience of the use of misoprostol as post-abortion care in Libreville, Gabon.

Calibrated delivery drape versus indirect gravimetric technique for the measurement of blood loss

Claims of misoprostol use based on blood sampling should be viewed with skepticism

Mortality of induced abortion, other outpatient surgical procedures, and common activities in the US

DMPA and HIV: do we need a trial?

WHO Multicountry Survey on Maternal and Newborn Health Research Network

A prospective open-label study of home use of mifepristone for medical abortion in Nepal

Safety, efficacy and acceptability of outpatient mifepristone-misoprostol MA through 70 days

The introduction of first trimester medical abortion in Armenia

Phone follow-up with SQPT after medical abortion in Moldova and Uzbekistan

What happens when we routinely give doxycycline to medical abortion patients?

Is One Of These Things Not Just Like The Other? Why Abortion can’t be Separated from Contraception

Mifepristone label laws and trends in use: recent experiences in four US states

Cervical Preparation Before Dilation and Evacuation Using Adjunctive Misoprostol or Mifepristone

How effective are the components of active management of the third stage of labor?

Reaching women where they are

Fifteen years: looking back and looking forward

Preventing postpartum hemorrhage at the community level

The MamaMiso study of self-administered misoprostol to prevent bleeding after childbirth in Uganda

Is It Safe to Provide Abortion Pills Over The Counter?

A crossover pharmacokinetic study of misoprostol by the oral, sublingual and buccal routes

Determining early medical abortion outcomes at 3, 7 and 14 days after mifepristone

Oxytocin via Uniject versus oral misoprostol for prevention of postpartum haemorrhage

Prospective study of home use of mifepristone and misoprostol for medical abortion up to 10weeks

Home use of mifepristone and misoprostol for MA up to 10weeks of pregnancy in Kazakhstan

Effects of Depot Medroxyprogesterone Acetate Injection Timing on MA Efficacy and Repeat Pregnancy

Simultaneous Administration Compared With a 24-Hour Mifepristone-Misoprostol Interval

Second trimester MA with mifepristone followed by unlimited dosing of buccal misoprostol in Armenia

800μg misoprostol and mucosal and systemic immune activation or the cervicovaginal microbiome

Misoprostol-induced fever and genetic polymorphisms in drug transporters

Serial Multilevel Urine Pregnancy Testing to Assess Medical Abortion Outcome

Self-administered multi-level pregnancy tests in simplified follow-up of medical abortion in Tunisia

Acceptability & feasibility of 400μg buccal misoprostol after 200 mg mife for early MA in Georgia

Alternatives to routine ultrasound for eligibility assessment prior to medical abortion

Medical abortion

Dissemination and implementing a core outcome set for medical and surgical abortion

Sixteen Years of Overregulation: Time to Unburden Mifeprex

Foley catheterisation versus oral misoprostol for induction of labour in hypertensive women in India

Results of a pilot study in the U.S. and Vietnam to assess the utility and acceptability of a MLPT

Misoprostol in the management of the third stage of labour in the home delivery in Gambia

Study finds that obtaining abortion pills from the internet is feasible in the US

Profound Hyperthermia After Postpartum Rectal Misoprostol Administration

Achieving community-based postpartum follow up in eastern Uganda

Wojdyla, Daniel

Misoprostol: adjunct treatment to standard uterotonics for treatment of PPH

Xinarianos, G

Misoprostol-induced fever and genetic polymorphisms in drug transporters

Yalvac, Serdar

Sublingual misoprostol vs oxytocin in women receiving prophylactic oxytocin

Yanow, Susan

Alternatives to mifepristone for early medical abortion

Misoprostol, Abortion, and the Law

Yarnall, Jillian

Non-physician clinicians can safely provide first trimester medical abortion

Yusupov, D

Mifepristone-Misoprostol for early Medical Abortion in Uzbekistan

Zeramdini, D

A two-pill sublingual misoprostol outpatient regimen following mife for MA through 70 days' LMP

Zhang, J. E.

Misoprostol-induced fever and genetic polymorphisms in drug transporters

Zhu, H

Letter to the editor on Emergency Contraception

Zhuk, S

Efficacy and acceptability of early mifepristone-misoprostol medical abortion in Ukraine

Zuberi, Nadeem F

Misoprostol in addition to routine treatment of postpartum hemorrhage in Pakistan

Administration of misoprostol by trained TBAs to prevent PPH in homebirths in Pakistan

Zweigenthal, Virginia

Perspectives on reproductive decision-making amongst HIV-infected individuals

Reproductive intentions among HIV-positive women and men